This website is intended for healthcare professionals only

Trending Topic

Glucose meter device with test strips and lancets on a blue textured background
14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Type 2 diabetes (T2D) is a progressive metabolic condition associated with obesity, cardiovascular disease and substantial morbidity and mortality.1 Despite the availability of multiple glucose-lowering therapies, a significant proportion of individuals with T2D fail to achieve recommended glycemic targets, particularly those with long disease duration, obesity and insulin resistance.2,3 In parallel, excess adiposity remains a major driver of […]

Uberto Pagotto, ESPE 2022: The global health burden and challenges of obesity

4 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 10th 2022

Paediatric obesity is a major threat to health and longevity. Around 7% of children worldwide have early onset severe obesity before the age of 7. In this touchENDOCRINOLOGY interview, Prof. Uberto Pagotto (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy) discusses the global health burden of obesity as well as the challenged obesity comes with. 

The abstract entitled: ‘Novel Advances in Obesity‘ was presented at the European Society for Paediatric Endocrinology, 15-17 Sept, 2022.

Questions:

  1. Could you give us a brief overview of the global health burden of obesity? (0:18)
  2. What are the challenges of the treatment of obesity? (2:29)

Disclosures: Uberto Pagotto has received honorarium from Bruno Pharma.

Support: Interview supported by Touch Medical Media. Interview conducted by Shanice Allen.

Recorded as a highlight of ESPE 2022

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup